Important Information

You are visiting the international Vantage Markets website, distinct from the website operated by Vantage Global Prime LLP
( www.vantagemarkets.co.uk ) which is regulated by the Financial Conduct Authority ("FCA").

This website is managed by Vantage Markets' international entities, and it's important to emphasise that they are not subject to regulation by the FCA in the UK. Therefore, you must understand that you will not have the FCA’s protection when investing through this website – for example:

  • You will not be guaranteed Negative Balance Protection
  • You will not be protected by FCA’s leverage restrictions
  • You will not have the right to settle disputes via the Financial Ombudsman Service (FOS)
  • You will not be protected by Financial Services Compensation Scheme (FSCS)
  • Any monies deposited will not be afforded the protection required under the FCA Client Assets Sourcebook. The level of protection for your funds will be determined by the regulations of the relevant local regulator.

If you would like to proceed and visit this website, you acknowledge and confirm the following:

  • 1.The website is owned by Vantage Markets' international entities and not by Vantage Global Prime LLP, which is regulated by the FCA.
  • 2.Vantage Global Limited, or any of the Vantage Markets international entities, are neither based in the UK nor licensed by the FCA.
  • 3.You are accessing the website at your own initiative and have not been solicited by Vantage Global Limited in any way.
  • 4.Investing through this website does not grant you the protections provided by the FCA.
  • 5.Should you choose to invest through this website or with any of the international Vantage Markets entities, you will be subject to the rules and regulations of the relevant international regulatory authorities, not the FCA.

Vantage wants to make it clear that we are duly licensed and authorised to offer the services and financial derivative products listed on our website. Individuals accessing this website and registering a trading account do so entirely of their own volition and without prior solicitation.

By confirming your decision to proceed with entering the website, you hereby affirm that this decision was solely initiated by you, and no solicitation has been made by any Vantage entity.

I confirm my intention to proceed and enter this website Please direct me to the website operated by Vantage Global Prime LLP, regulated by the FCA in the United Kingdom

By providing your email and proceeding to create an account on this website, you acknowledge that you will be opening an account with Vantage Global Limited, regulated by the Vanuatu Financial Services Commission (VFSC), and not the UK Financial Conduct Authority (FCA).

  • Please enter a valid email address

    • Please tick all to proceed

  • Please tick the checkbox to proceed
  • Please tick the checkbox to proceed
Proceed Please direct me to website operated by Vantage Global Prime LLP, regulated by the FCA in the United Kingdom.

×

Are you long or short on indices?

Trade Indices Now >
Long Or Short On Indices?
View More
Language
SEARCH
  • All
    Trading
    Platforms
    Academy
    Analysis
    Promotions
    About
  • Search
Keywords
  • Forex Trading
  • Vantage Rewards
  • Spreads
Popular Search
  • Trading Accounts
  • MT4
  • MT5
  • Copy Trading
  • Promotions
  • facebook
  • instagram
  • twitter
  • linkedin
  • youtube
  • tiktok
  • spotify
HomeRight Arrow Press ReleasesRight Arrow BrandingRight Arrow Vantage Markets Reveals “The Future of HealthTech” in the Latest Episode of The Vantage View

Vantage Markets Reveals “The Future of HealthTech” in the Latest Episode of The Vantage View

VantageFeaturing: Marc Despallieres, Chief Strategy & Trading Officer, Vantage
Branding
Vantage Markets Reveals “The Future of HealthTech” in the Latest Episode of The Vantage View

Port Vila, 25 July 2024 – Leading multi-asset broker, Vantage Markets (“Vantage”) is delighted to announce the release of the fifth episode of The Vantage View, “The Future of HealthTech”. The Vantage View video series is produced in collaboration with Bloomberg Media Studios and offers insightful financial analysis and perspectives.

This latest episode features Arnaud Bauer, Partner at L.E.K. Consulting, and delves into the transformative potential of healthcare technology as well as its promising investment opportunities. 

Bauer starts by discussing the rapid growth in healthcare data production, stating, “By 2025, the world is expected to produce 15,000 exabytes of healthcare data annually, versus only 2000 in 2020.” According to the research by L.E.K. Consulting, the healthcare industry alone accounts for approximately 30% of the world’s data volume. Additionally, the global healthcare data analytics market is projected to reach $1.5 to $2 billion by 2030. 

Highlighting the potential of investment opportunities within the markets, Bauer explains, “Healthcare data is increasingly used by pharma and medtech companies to bring new innovations to market, monitor products with available evidence data, and is now being leveraged by tech and AI companies. The breadth and depth of data, its longitudinality, and the quality of underlying data are key factors driving its value.”

Marc Despallieres, Chief Strategy and Trading Officer at Vantage, says, “We’re excited to unveil this latest episode, putting the spotlight on HealthTech. The focus on healthcare technology aims to provide a fresh perspective on a rapidly evolving sector, while uncovering hidden opportunities in an area that many investors haven’t fully explored yet. We’re confident the intersection of healthcare and technology is poised to drive significant innovation and investment potential.”

Previous episodes of The Vantage View have explored topics like A.I., the space economy, the circular economy, and sustainable mobility, featuring insights from leaders such as Dr. Ayesha Khanna, Simon Gwozdz, Dr. Seeram Ramakrishna, and Andrey Berdichevskiy.

Tune into the latest episode of The Vantage View to explore the dynamic world of HealthTech and its investment possibilities.